Výsledky vyhledávání - "E. V. Torshina"

Comparison of Pharmacokinetics, Bioequivalence, and Safety of Femorix® (Valenta Pharm Company, Russia) and Aubagio® (Sanofi Winthrop Industrie, France) Film-Coated Tablets (14 mg)

Autor: A. V. Belostotskii, V. S. Arnautov, I. G. Lopukhov, E. V. Torshina, D. V. Reikhart, A. A. Globenko

Publikováno v: Pharmaceutical Chemistry Journal. 51:954-959

The pharmacokinetics, bioequivalence, and safety of Femorix® (Valenta Pharm Co., Russia) and Aubagio® (SanofiWinthrop Industrie, France) film-coated tablets (14 mg) were compared in a double-blind randomized investigation in parallel groups of heal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9495e7bb9e90ecf12982f179990984bd
https://doi.org/10.1007/s11094-018-1722-8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Comparative Bioavailability of Tizanidine in Three Dosage Forms (6-MG Delayed-Release Tablets, Sirdalud Preparation, and 2-MG Tablets)

Autor: E. V. Torshina, A. V. Belostotskii, V. S. Artnautov, D. V. Reikhart, A. V. Kapashin, V. G. Kukes

Publikováno v: Pharmaceutical Chemistry Journal. 50:394-403

Valenta Pharm Co. compared the pharmacokinetic parameters in healthy volunteers of three prototype tizanidine dosage forms (delayed-release 6-mg tablets) and the reference drug sirdalud (2-mg tablets for a total dose of 6 mg, three tablets). This all

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::510e2b469fdfbeaa7e8606137cc77c18
https://doi.org/10.1007/s11094-016-1458-2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání